BioWorld MedTech

April 15, 2014

Medtronic faces debilitating U.S. injunction on CoreValve sales

Edwards Lifesciences (Irvine, California) has won an important battle in a six-year patent war with Medtronic (Minneapolis) over Medtronic's CoreValve transcatheter aortic valve replacement (TAVR/TAVI) system. Read More

Financings Roundup: Sant Ventures boosts size of most recent fund to $139 million

Final data from PRECISE trial to bepublished in American Heart Journal

Washington Roundup: Importers beware; Health Canada report cites SOPs for distribution

International report: Chiyoda Technol to distribute Mevion's S250 in Japan

Agreements/contracts: SBG Technology Solutions awarded VA contract extension for VistA

Deals roundup: Chindex receives M&A cash bid from buyer consortium

HIT Roundup: Osler to use Medworxx patient flow platform

Syneron gets clearance for UltraShape system

Product briefs

Briefly Noted

People in Places

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for July 24, 2026.

To viral or not to viral: In vivo CAR T debates delivery tech

BioWorld

The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 21, 2026

Tree in the shape of human head losing leaves

KBN-2201 reverses key features of Alzheimer’s in mice

BioWorld Science

Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.

Click chemistry drug bound to pancreatic cancer cells from mice

In vivo click ADCs could address tumor heterogeneity

BioWorld

Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...